Susceptibility of anaerobic bacteria to BAY v 3522 | Zendy

C. E. Nord | Zendy; M Rylander | Zendy; S. Ragnar Norrby | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Susceptibility of anaerobic bacteria to BAY v 3522

Author(s) -

C. E. Nord,

M Rylander,

S. Ragnar Norrby

Publication year - 1991

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.35.3.594

Subject(s) - cefoxitin , clindamycin , cefadroxil , amoxicillin , agar dilution , metronidazole , anaerobic bacteria , cefuroxime , antibiotics , anaerobic exercise , microbiology and biotechnology , antibacterial agent , bay , medicine , doxycycline , bacteria , chemistry , biology , cephalosporin , staphylococcus aureus , minimum inhibitory concentration , physiology , civil engineering , engineering , genetics

The activity of BAY v 3522 against 340 strains of anaerobic bacteria was determined by an agar dilution method. Its activity was compared with those of amoxicillin, amoxicillin-clavulanate, cefaclor, cefadroxil, cefoxitin, cefuroxime, cephalexin, clindamycin, doxycycline, and metronidazole. BAY v 3522, amoxicillin-clavulanate, cefoxitin, clindamycin, and metronidazole were the most active agents tested. On the basis of these results, BAY v 3522 appears to have an antibacterial activity that warrants further investigation in clinical trials.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research